A group of investigators at the prestigious Dana-Farber/Children's Hospital Cancer Center in Boston believe they may have identified the Achilles heel for a common malignant tumor found in pediatric oncology.
Personalized medicine has been the holy grail of diagnostics and biomarkers for some time, but at last, it seems like it is becoming a reality. Jan Groen, CEO at MDxHealth, spoke to FierceBiomarkers at BIO2012 about this growing field.
Cancer systems biology algorithms have led researchers to two genes that collaborate to cause an aggressive brain tumor. Researchers from Columbia University and oncology drug discovery company
A potential treatment for small cell lung cancer may head to clinical trials next year following the publication of promising results of a mice study in the journal Cancer Research. Researchers from
The OnCore clinical research management system "sports a sleek new user interface" and incorporates hundreds of enhancement requests provided by 20 research organizations, according to developer
Late last week GlaxoSmithKline announced a newly re-engineered program for cancer R&D . The pharma giant had
Celldex Therapeutics has struck a deal to use 3M's toll-like receptor (TLR) agonist compounds--useful as vaccine adjuvants--for a slate of new oncology vaccines in development. 3M Drug Delivery